LIU Yu, NIU Shuli, LI Mengyue, LI Xiaotian. Research progress of curcumin in the treatmentof non-alcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 118-124. DOI: 10.7619/jcmp.20200328
Citation: LIU Yu, NIU Shuli, LI Mengyue, LI Xiaotian. Research progress of curcumin in the treatmentof non-alcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 118-124. DOI: 10.7619/jcmp.20200328

Research progress of curcumin in the treatmentof non-alcoholic fatty liver disease

  • Non-alcoholic fatty liver disease (NAFLD) is one of causes of chronic liver injury, and the pathogenesis is complex. Insulin resistance, oxidative stress, intestinal-hepatic axis and mitochondrial dysfunction lead to the occurrence and development of NAFLD. Curcumin, a natural polyphenol, is a potential drug for the treatment of NAFLD, and has been widely studied in experimental researches. This study reviewed pathogenesis of NAFLD and the therapeutic effect of curcumin on NAFLD.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return